Verified Service Provider in Rwanda
Molecular Diagnostics Labs in Rwanda
Engineering Excellence & Technical Support
Molecular Diagnostics Labs solutions for Clinical & Diagnostic Labs. High-standard technical execution following OEM protocols and local regulatory frameworks.
Advanced PCR & Sequencing Capabilities
Equipped with state-of-the-art PCR and next-generation sequencing (NGS) platforms, our labs enable rapid and accurate identification of infectious agents, genetic predispositions, and the characterization of microbial resistance patterns, crucial for effective disease control and public health initiatives in Rwanda.
Genomic Surveillance for Emerging Threats
Leveraging cutting-edge genomic sequencing technologies, we establish robust surveillance systems to detect and track novel pathogens and their mutations in real-time. This proactive approach is vital for anticipating and responding swiftly to potential outbreaks and safeguarding the health of the Rwandan population.
Data-Driven Precision Medicine Integration
Our molecular diagnostics empower a shift towards data-driven precision medicine. By providing detailed genetic and molecular insights, we support clinicians in tailoring treatments, optimizing patient outcomes, and contributing to the development of more personalized healthcare strategies within Rwanda.
What Is Molecular Diagnostics Labs In Rwanda?
Molecular diagnostics laboratories in Rwanda represent specialized facilities equipped to perform complex tests that analyze biological molecules, primarily DNA and RNA. These labs are crucial for identifying genetic material and detecting specific pathogens, genetic variations, or biomarkers associated with diseases. Their operations are grounded in molecular biology techniques, including Polymerase Chain Reaction (PCR), gene sequencing, nucleic acid amplification tests (NAATs), and various hybridization assays. The core function is to provide highly sensitive and specific diagnostic information for a range of medical and public health applications, contributing significantly to disease surveillance, outbreak investigation, personalized medicine, and research within the Rwandan healthcare landscape.
| Who Needs Molecular Diagnostics? | Typical Use Cases in Rwanda | ||
|---|---|---|---|
| Individuals presenting with symptoms suggestive of specific infectious diseases (e.g., viral, bacterial, parasitic). | Diagnosis of infectious diseases such as Tuberculosis (including drug-resistant strains), HIV, Hepatitis B and C, Malaria, COVID-19, and other emerging or re-emerging infectious agents. | Confirmation of suspected infections, especially where traditional methods lack sensitivity or specificity. | |
| Patients with suspected genetic disorders or hereditary conditions. | Genetic testing for inherited diseases, carrier screening, and prenatal diagnostics. | Identification of genetic predispositions to certain cancers or other chronic conditions. | |
| Individuals undergoing treatment for cancer. | Personalized medicine approaches, including pharmacogenomic testing to predict drug response and optimize treatment regimens. | Monitoring of disease progression and treatment efficacy through the detection of specific biomarkers. | |
| Public health officials and researchers. | Disease surveillance and outbreak investigations to identify the source, transmission patterns, and genetic evolution of pathogens. | Food and water safety testing for the detection of microbial contamination. | Forensic investigations requiring DNA analysis. |
| Healthcare providers requiring definitive diagnostic information. | Differential diagnosis when clinical presentations are ambiguous. | Rapid identification of pathogens to guide appropriate treatment strategies. |
Key Components and Functions of Molecular Diagnostics Labs in Rwanda:
- Nucleic Acid Extraction and Purification: Isolating DNA or RNA from biological samples (e.g., blood, saliva, tissue, swabs).
- Amplification Techniques: Employing methods like PCR to exponentially increase the quantity of target DNA/RNA for detection.
- Detection and Analysis: Utilizing techniques such as gel electrophoresis, real-time PCR (qPCR), microarrays, or sequencing to identify the presence and quantity of specific molecular targets.
- Data Interpretation and Reporting: Analyzing raw data to provide actionable diagnostic results for clinicians and public health officials.
- Quality Assurance and Control: Implementing rigorous protocols to ensure the accuracy, reliability, and reproducibility of test results.
Who Needs Molecular Diagnostics Labs In Rwanda?
Molecular diagnostics labs are crucial for advancing healthcare in Rwanda, offering precise and rapid identification of diseases, enabling timely and effective treatment. Their services are essential for a range of stakeholders across the healthcare ecosystem, from individual patients to national health initiatives.
| Target Customer/Department | Specific Needs & Services |
|---|---|
| Hospitals and Clinics (Public & Private) | - Infectious Disease Diagnosis: Rapid identification of viral (e.g., HIV, Hepatitis, Influenza, COVID-19), bacterial (e.g., Tuberculosis, Salmonella), and parasitic infections for targeted treatment. - Oncology: Genetic testing for cancer diagnosis, prognosis, and personalized therapy selection (e.g., HPV for cervical cancer, EGFR mutations in lung cancer). - Genetic Disorders: Prenatal and postnatal screening for inherited conditions. - Antimicrobial Resistance (AMR) Testing: Identifying drug-resistant strains to guide antibiotic use. - Blood Transfusion Services: HLA typing and screening for infectious agents in blood products. - Microbiology Departments: Advanced pathogen identification and characterization. |
| Public Health Programs & Ministries of Health | - Disease Surveillance: Monitoring the prevalence and spread of infectious diseases at a national level. - Outbreak Investigations: Rapidly identifying the causative agents of epidemics to inform public health responses. - Vaccine Efficacy Monitoring: Assessing the impact of vaccination campaigns. - National Health Security: Strengthening the country's capacity to detect and respond to health threats, including novel pathogens. - Epidemiology Units: Providing data for public health policy and interventions. |
| Research Institutions & Universities | - Pathogen Discovery: Identifying new or emerging infectious agents. - Disease Mechanism Studies: Understanding the genetic and molecular basis of diseases. - Drug Development: Facilitating research into new diagnostic and therapeutic tools. - Public Health Research: Generating evidence for health program improvement. - Training & Capacity Building: Providing hands-on experience for future scientists and healthcare professionals. |
| Veterinary Services (Ministry of Agriculture, Animal Husbandry & Fisheries) | - Zoonotic Disease Control: Diagnosing animal diseases transmissible to humans (e.g., Avian Influenza, Rabies). - Livestock Health: Identifying infectious diseases affecting animal populations, crucial for food security and economic stability. - Food Animal Safety: Ensuring meat and other animal products are free from pathogens. - Animal Disease Surveillance: Monitoring and controlling animal disease outbreaks. |
| Food Safety Agencies (e.g., Rwanda Standards Board) | - Pathogen Detection in Food: Identifying harmful bacteria, viruses, and parasites in food products to ensure public safety. - Traceability & Source Identification: Determining the origin of foodborne illness outbreaks. - Compliance Monitoring: Verifying adherence to food safety regulations. |
| Individual Patients (Indirectly via Healthcare Providers) | - Accurate Diagnosis: Receiving precise identification of their illness, leading to appropriate treatment. - Personalized Medicine: Benefiting from treatments tailored to their specific genetic makeup or disease profile. - Reduced Morbidity & Mortality: Faster and more accurate diagnoses lead to better health outcomes. - Peace of Mind: Early and definitive diagnosis can alleviate anxiety. |
| Emergency Response Units (e.g., Rwanda Biomedical Centre, Disaster Management Agencies) | - Rapid Pathogen Identification during Emergencies: Quickly identifying agents responsible for biological threats or public health crises. - Toxin Detection: Identifying chemical or biological toxins in environmental samples or affected individuals. |
Target Customers and Departments
- Hospitals and Clinics
- Public Health Programs
- Research Institutions
- Veterinary Services
- Food Safety Agencies
- Individual Patients (indirectly)
- Emergency Response Units
Molecular Diagnostics Labs Process In Rwanda
Molecular diagnostics laboratories in Rwanda play a crucial role in disease detection, surveillance, and treatment monitoring. The process, from an initial inquiry to the final execution of a diagnostic test, involves a series of well-defined steps to ensure accuracy, efficiency, and patient safety. This workflow is essential for providing timely and reliable diagnostic information to healthcare providers and public health officials.
| Stage | Key Activities | Purpose | Key Personnel Involved |
|---|---|---|---|
| Inquiry & Request | Healthcare provider identifies need, submits requisition, specifies tests. | Initiate testing process, define diagnostic needs. | Clinician, Public Health Officer |
| Sample Collection & Transport | Patient sample collection, proper labeling, cold chain maintenance, delivery to lab. | Obtain viable and uncontaminated biological material. | Nurse, Phlebotomist, Lab Technician (for transport) |
| Sample Reception & Registration | Receive samples, verify against requisition, log into LIMS, assign unique ID. | Track and trace samples, ensure data accuracy. | Lab Receptionist, Lab Technician |
| Sample Processing & Extraction | Initial sample preparation, nucleic acid (DNA/RNA) isolation. | Isolate target genetic material from other cellular components. | Lab Technician, Molecular Biologist |
| Amplification | Using PCR/qPCR to amplify target nucleic acid sequences. | Generate sufficient copies of target for detection. | Lab Technician, Molecular Biologist |
| Detection & Analysis | Identify amplified targets using fluorescence, electrophoresis, etc.; analyze data. | Determine presence/absence of genetic targets. | Lab Technician, Molecular Biologist |
| Quality Control (QC) | Run controls, perform calibration, monitor assay performance. | Ensure accuracy, reliability, and validity of test results. | Lab Technician, Quality Assurance Officer |
| Data Interpretation & Reporting | Analyze results in context of controls and clinical data; generate report. | Translate raw data into meaningful diagnostic information. | Molecular Biologist, Pathologist (if applicable) |
| Result Communication | Transmit report to requesting clinician/authority; discuss findings. | Inform decision-making for patient care or public health response. | Lab Manager, Molecular Biologist |
| Archiving & Disposal | Store data and reports; dispose of biohazardous waste safely. | Maintain records, ensure compliance with safety regulations. | Lab Technician, Waste Management Personnel |
Molecular Diagnostics Lab Process in Rwanda: Workflow from Inquiry to Execution
- {"title":"1. Inquiry and Sample Request","description":"The process begins when a healthcare provider or authorized entity identifies a need for molecular diagnostic testing for a patient or a population. This triggers an inquiry or a formal sample request, outlining the suspected condition, patient demographics, and the specific test(s) required. This might be initiated through a laboratory information management system (LIMS), a requisition form, or direct communication with the lab."}
- {"title":"2. Sample Collection and Preparation","description":"Once a request is confirmed, appropriate biological samples (e.g., blood, saliva, urine, tissue, swabs) are collected from the patient following strict protocols. Proper collection, labeling, and preservation are critical to maintain sample integrity. The samples are then transported to the molecular diagnostics laboratory under controlled conditions to prevent degradation or contamination."}
- {"title":"3. Sample Reception and Registration","description":"Upon arrival at the lab, samples are received, logged, and registered in the LIMS. This involves verifying the sample against the requisition form, assigning a unique laboratory identifier, and documenting its receipt time, condition, and any relevant details. This step ensures traceability and accountability."}
- {"title":"4. Sample Processing and DNA/RNA Extraction","description":"The core molecular diagnostic process begins with sample processing. Depending on the sample type and the assay, this might involve cell lysis or other initial preparation steps. The crucial next phase is nucleic acid (DNA or RNA) extraction, where the genetic material is isolated from the rest of the cellular components. Various extraction kits and automated systems are employed for this purpose."}
- {"title":"5. Amplification (e.g., PCR)","description":"Following extraction, the target nucleic acid sequences are amplified to generate a sufficient quantity for detection. The most common amplification technique in molecular diagnostics is the Polymerase Chain Reaction (PCR) or its real-time variant (qPCR). This process creates millions of copies of specific DNA segments."}
- {"title":"6. Detection and Analysis","description":"Amplified nucleic acids are then detected using various methods. For qPCR, fluorescence signals are monitored in real-time. Other methods may include gel electrophoresis, sequencing, or hybridization assays. The generated data is analyzed to determine the presence or absence of specific genetic targets (e.g., pathogens, mutations)."}
- {"title":"7. Quality Control and Validation","description":"Throughout the entire workflow, rigorous quality control (QC) measures are implemented. This includes using positive and negative controls for each assay run, proficiency testing, and regular calibration of equipment. Validation of new assays and reagents is also paramount to ensure accuracy and reliability."}
- {"title":"8. Data Interpretation and Reporting","description":"Once the analysis is complete and QC checks are satisfactory, the results are interpreted by trained laboratory personnel. This interpretation considers the amplified signals, control data, and established reference ranges. A comprehensive report is then generated, detailing the test performed, results obtained, and any relevant clinical information."}
- {"title":"9. Result Communication and Follow-up","description":"The final molecular diagnostic report is communicated to the requesting healthcare provider or relevant public health authority. Depending on the urgency and nature of the results, this might involve direct phone calls for critical findings or electronic transmission through the LIMS. The lab may also provide further consultation or guidance on the implications of the results."}
- {"title":"10. Data Archiving and Sample Disposal","description":"All raw data, processed results, and reports are securely archived according to laboratory and regulatory guidelines. This ensures data integrity for future reference and audits. Used reagents and biological samples are then disposed of safely and in compliance with biohazard waste management protocols."}
Molecular Diagnostics Labs Cost In Rwanda
The cost of molecular diagnostics laboratory services in Rwanda is influenced by a variety of factors, leading to a range of prices for specific tests. These factors include the complexity of the assay, the reagents and consumables used, the equipment and technology employed, the expertise of the laboratory personnel, and overhead costs associated with running a certified laboratory. The pricing is generally presented in Rwandan Francs (RWF).
| Type of Molecular Diagnostic Test | Estimated Price Range (RWF) | Notes |
|---|---|---|
| COVID-19 PCR Test (Standard) | 30,000 - 50,000 | Price can vary between public and private labs, and may include sample collection. |
| Viral Load Testing (e.g., HIV) | 40,000 - 70,000 | Essential for monitoring treatment efficacy. |
| Hepatitis B/C PCR Detection | 35,000 - 60,000 | Used for diagnosis and monitoring. |
| Tuberculosis (TB) PCR Detection (e.g., GeneXpert) | 30,000 - 50,000 | Faster and more accurate than traditional methods. |
| Genotyping/Sequencing (e.g., for drug resistance) | 100,000 - 300,000+ | More complex and expensive due to specialized equipment and analysis. |
| Sexually Transmitted Infections (STIs) Multiplex PCR | 50,000 - 90,000 | Detects multiple pathogens in a single test. |
| Malaria PCR Detection | 25,000 - 45,000 | Highly sensitive for early detection. |
Key Pricing Factors for Molecular Diagnostics in Rwanda:
- Test Complexity: Simpler PCR tests are typically less expensive than more complex multiplex assays or sequencing-based diagnostics.
- Reagent and Consumable Costs: The specific kits, enzymes, primers, probes, and other consumables required for a test are a major cost driver. High-demand or specialized reagents can increase prices.
- Technology and Equipment: Laboratories using state-of-the-art equipment, such as automated sample preparation systems or high-throughput sequencers, may have higher costs passed on to the consumer, though this can also lead to greater efficiency and potentially lower costs for high-volume testing.
- Personnel Expertise: Highly skilled technicians and scientists are essential for accurate molecular diagnostics. Their salaries and ongoing training contribute to the overall cost.
- Laboratory Accreditation and Quality Control: Maintaining international standards for accreditation and rigorous quality control measures adds to operational expenses.
- Overhead Costs: This includes facility rent, utilities, maintenance of equipment, and administrative support.
- Reimbursement Policies: While not directly a pricing factor for the patient, government and insurance reimbursement rates can indirectly influence the pricing strategies of laboratories.
- Volume of Testing: Higher-volume laboratories may benefit from economies of scale, potentially leading to slightly lower per-test costs.
Affordable Molecular Diagnostics Labs Options
Affordable molecular diagnostics labs are crucial for expanding access to essential health information, enabling early disease detection, personalized treatment, and effective public health monitoring. Several options exist to make these services more accessible, focusing on value and cost-effectiveness. Understanding value bundles and implementing smart cost-saving strategies are key to achieving this affordability.
| Cost-Saving Strategy | Description | Impact on Affordability |
|---|---|---|
| Bulk Purchasing & Volume Discounts | Negotiating lower prices with suppliers for reagents, consumables, and equipment based on high testing volumes. | Reduces per-test costs, making overall operations more economical. |
| Automation & High-Throughput Platforms | Investing in automated systems that can process a large number of samples efficiently with minimal manual labor. | Decreases labor costs per sample and increases turnaround time, improving operational efficiency. |
| Centralized Testing Facilities | Consolidating testing across multiple smaller clinics or hospitals into a single, larger, and more efficient laboratory. | Leverages economies of scale, reduces redundant infrastructure, and optimizes resource utilization. |
| Outsourcing Non-Core Functions | Contracting out administrative tasks, IT support, or specialized assay development to third-party providers who can do it more cost-effectively. | Frees up internal resources and reduces overhead costs associated with managing these functions. |
| Strategic Partnerships & Collaborations | Teaming up with other healthcare providers, research institutions, or diagnostic companies to share resources, expertise, and bulk purchasing power. | Distributes costs, expands access to advanced technologies, and can lead to joint funding opportunities. |
| Optimized Workflow & Lean Management | Implementing efficient laboratory workflows, minimizing waste, and continuously improving processes to reduce turnaround times and operational inefficiencies. | Reduces waste of reagents and time, leading to lower operating expenses. |
| Development of In-House Assays | For high-volume tests, developing and validating in-house assays can be more cost-effective than relying on expensive commercial kits. | Can significantly reduce reagent costs for frequently performed tests. |
| Telehealth Integration | Using telehealth platforms to facilitate sample collection, patient consultation, and result delivery, reducing the need for in-person visits and associated costs. | Lowers logistical costs and improves patient convenience. |
| Focus on Cost-Effective Technologies | Prioritizing diagnostic platforms and technologies that offer a good balance of accuracy, sensitivity, and cost per test. | Ensures that investments in technology are financially sustainable without compromising diagnostic quality. |
Understanding Value Bundles
- {"title":"What are Value Bundles?","description":"Value bundles in molecular diagnostics are packages of services that are offered together at a reduced price compared to purchasing each service individually. They aim to provide a comprehensive solution for specific clinical needs or patient populations."}
- {"title":"Types of Value Bundles","description":"Common bundles include: diagnostic panels for a specific disease category (e.g., infectious diseases, cancer), companion diagnostics bundled with a targeted therapy, or preventative screening packages. These bundles often streamline the testing process and offer clear cost predictability."}
- {"title":"Benefits of Value Bundles","description":"Benefits include potential cost savings for patients and healthcare providers, simplified ordering and reporting, improved diagnostic yield through comprehensive testing, and better patient management by addressing multiple needs in one go."}
Verified Providers In Rwanda
In Rwanda's evolving healthcare landscape, identifying reliable and qualified healthcare providers is paramount for individuals seeking quality medical services. Franance Health stands out as a leading entity, distinguished by its rigorous credentialing process and unwavering commitment to excellence. This makes them a benchmark for verified providers, ensuring patients receive care from trusted professionals.
| Why Franance Health Represents the Best Choice | Benefits for Patients |
|---|---|
| Rigorous Vetting Process: Franance Health employs a multi-faceted credentialing system that goes beyond basic licensing, ensuring a higher caliber of providers. | Peace of Mind: Knowing you are receiving care from meticulously vetted professionals alleviates concerns about quality and safety. |
| Access to Specialized Care: Their network includes a wide range of specialists, facilitating access to expert opinions and treatments for complex conditions. | Improved Health Outcomes: The emphasis on qualified and experienced practitioners directly translates to better diagnostic accuracy and more effective treatment plans. |
| Commitment to Quality Standards: Franance Health actively monitors and upholds stringent quality benchmarks, ensuring consistent service delivery. | Efficient and Reliable Healthcare: Reduced risk of misdiagnosis or suboptimal treatment leads to a more efficient and positive healthcare journey. |
| Patient-Centric Approach: Verified providers are encouraged to adopt a patient-first philosophy, prioritizing communication, empathy, and personalized care. | Enhanced Patient Experience: From the moment of consultation to recovery, patients can expect a more supportive and responsive healthcare interaction. |
| Transparency and Trust: The clear verification process builds trust, empowering patients to make informed decisions about their healthcare providers. | Empowered Decision-Making: Access to information about a provider's credentials allows patients to confidently select the best care for their needs. |
Key Credentials of Verified Providers:
- Licensing and Registration: All providers affiliated with verified networks, like Franance Health, undergo thorough checks to ensure they possess valid and up-to-date licenses from the Rwanda Health Professions Council (RHPC) and relevant regulatory bodies.
- Specialization and Expertise: Verification confirms that practitioners have the necessary qualifications and documented experience in their specific medical fields, ranging from general practice to highly specialized surgeries.
- Continuing Professional Development (CPD): Franance Health requires providers to demonstrate ongoing commitment to learning and skill enhancement, ensuring they are abreast of the latest medical advancements and best practices.
- Clean Disciplinary Record: A crucial aspect of verification involves thorough background checks to confirm that providers have no history of malpractice or disciplinary actions.
- Infrastructure and Equipment Review: For facilities, verification extends to assessing the availability of appropriate medical equipment, technology, and adherence to safety and hygiene standards, as mandated by Rwandan health regulations.
- Patient Feedback and Outcomes: While not always a primary credential, a strong track record of positive patient feedback and successful treatment outcomes is often a consideration for top-tier verified providers.
Scope Of Work For Molecular Diagnostics Labs
This document outlines the Scope of Work (SOW) for Molecular Diagnostics Laboratories, detailing key technical deliverables and standard specifications essential for their operation and reporting. It covers the fundamental aspects of molecular diagnostic testing, from sample handling to data analysis and reporting, ensuring accuracy, reliability, and regulatory compliance.
| Section | Description | Standard Specifications/Requirements |
|---|---|---|
| Sample Handling and Processing | Receipt, storage, accessioning, and preparation of biological specimens for molecular analysis. | Adherence to CLIA/CAP/ISO 15189 guidelines, proper chain of custody, temperature-controlled storage, appropriate containment levels (BSL-2/3 as needed). |
| Nucleic Acid Extraction | Isolation of DNA or RNA from various biological matrices. | Validated extraction kits/protocols, documented lot numbers, specified elution volumes, nucleic acid yield and purity assessment (e.g., NanoDrop, Qubit). |
| Amplification (PCR/Isothermal) | Target amplification for sensitive detection. | Validated primers/probes, optimized cycling conditions (PCR) or incubation temperatures (isothermal), internal controls (IC), positive and negative controls, documented reaction mixes. |
| Detection and Analysis | Quantification and/or qualitative detection of amplified targets. | Validated detection platforms (e.g., real-time PCR, NGS, microarrays), appropriate software for data analysis, limit of detection (LoD), limit of quantification (LoQ) studies, analytical sensitivity and specificity data. |
| Quality Control | Ensuring the accuracy and reliability of test results. | Inclusion of daily QC samples (positive, negative, amplification controls), lot-to-lot reagent QC, ongoing QC monitoring, documented QC review and approval processes. |
| Instrument Calibration and Maintenance | Ensuring instruments perform within specifications. | Regular calibration schedules, documented maintenance logs, manufacturer-recommended QC checks, service records. |
| Reagent Management | Tracking and proper use of reagents. | Lot number tracking, expiry date monitoring, storage condition verification, reagent stability studies, traceability to manufacturer specifications. |
| Data Management and Reporting | Secure storage, analysis, and reporting of patient results. | Secure LIMS/LIS integration, anonymization/de-identification of patient data, audit trails, clear and concise report formats, turnaround time (TAT) monitoring, report validation by qualified personnel. |
| Regulatory Compliance | Adherence to relevant national and international regulations. | Compliance with CLIA, CAP, ISO 13485/15189, FDA (for IVD devices), GDPR/HIPAA, documented policies and procedures demonstrating compliance. |
| Proficiency Testing (PT) | External assessment of laboratory performance. | Participation in accredited PT programs, timely submission of samples, analysis of results, corrective action implementation for any discrepancies. |
Key Technical Deliverables
- Validated Analytical Methods and Protocols
- Quality Control (QC) Procedures and Documentation
- Proficiency Testing (PT) Program Participation and Results
- Instrument Calibration and Maintenance Records
- Reagent Lot Verification and Traceability
- Specimen Accessioning and Tracking System
- Data Analysis and Interpretation Algorithms
- Test Reports with Clear Interpretation and Recommendations
- Audit Trails and Data Security Measures
- Standard Operating Procedures (SOPs) for all processes
Service Level Agreement For Molecular Diagnostics Labs
This Service Level Agreement (SLA) outlines the guaranteed response times and uptime for molecular diagnostics laboratory services provided by [Your Company Name] to [Client Name]. This agreement ensures the reliability and efficiency of our diagnostic services to support your critical healthcare operations.
| Service Type | Uptime Guarantee | Response Time (Sample Receipt to Preliminary Report) | Response Time (Preliminary to Final Report) |
|---|---|---|---|
| Routine Molecular Diagnostics | 99.5% Uptime | Within 24 business hours | Within 24 business hours |
| On-Demand Molecular Diagnostics | 99.0% Uptime | Within 12 business hours | Within 12 business hours |
| Emergency Molecular Diagnostics | 98.0% Uptime | Within 4 business hours | Within 4 business hours |
Scope of Services
- On-demand molecular diagnostic testing.
- Routine molecular diagnostic testing.
- Emergency molecular diagnostic testing.
- Data reporting and interpretation.
- Technical support and consultation.
In-Depth Guidance
Frequently Asked Questions
Phase 02: Execution
Ready when you are
Let's scope your Molecular Diagnostics Labs in Rwanda project in Rwanda.
OEM Approved
54Regions
Scaling healthcare logistics and technical systems across the entire continent.